- Home
- ROIV vs PEGA Comparison
ROIV vs PEGA Comparison
Compare ROIV & PEGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- PEGA
- Stock Information
- Founded
- ROIV 2014
- PEGA 1983
- Country
- ROIV United Kingdom
- PEGA United States
- Employees
- ROIV N/A
- PEGA N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- PEGA EDP Services
- Sector
- ROIV Health Care
- PEGA Technology
- Exchange
- ROIV Nasdaq
- PEGA Nasdaq
- Market Cap
- ROIV 8.4B
- PEGA 7.8B
- IPO Year
- ROIV N/A
- PEGA 1996
- Fundamental
- Price
- ROIV $10.79
- PEGA $98.97
- Analyst Decision
- ROIV Buy
- PEGA Buy
- Analyst Count
- ROIV 4
- PEGA 13
- Target Price
- ROIV $17.50
- PEGA $100.38
- AVG Volume (30 Days)
- ROIV 5.9M
- PEGA 1.0M
- Earning Date
- ROIV 05-29-2025
- PEGA 04-22-2025
- Dividend Yield
- ROIV N/A
- PEGA 0.12%
- EPS Growth
- ROIV N/A
- PEGA 156.48
- EPS
- ROIV N/A
- PEGA 2.14
- Revenue
- ROIV $122,585,000.00
- PEGA $1,642,666,000.00
- Revenue This Year
- ROIV N/A
- PEGA $11.41
- Revenue Next Year
- ROIV N/A
- PEGA $5.82
- P/E Ratio
- ROIV N/A
- PEGA $46.33
- Revenue Growth
- ROIV 140.04
- PEGA 14.29
- 52 Week Low
- ROIV $8.73
- PEGA $55.71
- 52 Week High
- ROIV $13.06
- PEGA $113.67
- Technical
- Relative Strength Index (RSI)
- ROIV 50.06
- PEGA 74.91
- Support Level
- ROIV $10.58
- PEGA $96.88
- Resistance Level
- ROIV $11.77
- PEGA $99.51
- Average True Range (ATR)
- ROIV 0.34
- PEGA 2.26
- MACD
- ROIV -0.07
- PEGA 0.42
- Stochastic Oscillator
- ROIV 17.65
- PEGA 94.90
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PEGA Pegasystems Inc.
Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.